SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Prestige Biologics Names Lim Young-soo CEO

Prestige Biologics appointed Im Young-soo as CEO.

SquawkNews Desk

Related stories

Jiangxi Copper falls more than 6% again intraday M impact | EQUITY | Oct 30, 2026, 08:57 AM UTC Court Accepts Bankruptcy Liquidation Application Against CNG Weihai A court accepted a bankruptcy liquidation application against CNG Weihai on Oct. 29, 2026. M impact | EQUITY | Oct 30, 2026, 08:56 AM UTC FOKUS 3-BP Reports Record Third-Quarter Profit M impact | EQUITY | Oct 30, 2026, 08:51 AM UTC BP reports record $8.46 billion third-quarter profit, beats forecasts M impact | EQUITY | Oct 30, 2026, 08:49 AM UTC Intel Reports Third-Quarter Profit; Shares Fall on Weak Outlook Intel reported a profit for the third quarter, while its shares fell amid weak projections. M impact | EQUITY | Oct 30, 2026, 08:43 AM UTC 2CRSI Shares Fall 11.4% After Independent Expert Conclusions Published 2CRSI published conclusions from an independent expert appointed following a Grizzly Research report. M impact | EQUITY | Oct 30, 2026, 08:41 AM UTC